Free Trial

How major US stock indexes fared Friday, 8/8/2025

Key Points

  • Wall Street experienced a positive trading session on Friday, marking the third winning week out of the last four for major indexes.
  • The S&P 500 rose 0.8%, closing just shy of its recent record, while the Nasdaq added 1% to its own record set the previous day.
  • Expedia and Gilead Sciences reported strong earnings that easily exceeded analysts' forecasts and raised their outlooks.
  • For the week, the S&P 500 increased by 2.4% and the Nasdaq saw a 3.9% rise, contributing to year-to-date gains of 8.6% and 11.1% respectively.
  • Want stock alerts on Gilead Sciences? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Stocks rose on Wall Street, marking their third winning week in the last four.

The S&P 500 rose 0.8% Friday, leaving the index just shy of the record it set last week. The Dow Jones Industrial Average climbed 0.5%, and the Nasdaq added 1% to the record it set a day earlier.

Expedia and Gilead Sciences rose sharply after reporting results that easily beat analysts’ forecasts. Both companies also raised their outlooks. Asian markets closed mostly lower except in Tokyo, where the Nikkei rose 1.9%. European markets were mixed. Treasury yields rose in the bond market.

On Friday:

The S&P 500 rose 49.45 points, or 0.8%, to 6,389.45.

The Dow Jones Industrial Average rose 206.97 points, or 0.5%, to 44,175.61.

The Nasdaq composite rose 207.32 points, or 1%, to 21,450.02.

The Russell 2000 index of smaller companies rose 3.70 points, or 0.2%, to 2,218.42.

For the week:

The S&P 500 is up 151.44 points, or 2.4%.

The Dow is up 587.03 points, or 1.3%.

The Nasdaq is up 799.89 points, or 3.9%.

The Russell 2000 is up 51.64 points, or 2.4%.

For the year:

The S&P 500 is up 507.82 points, or 8.6%.

The Dow is up 1,631.39 points, or 3.8%.

The Nasdaq is up 2,139.23 points, or 11.1%.

The Russell 2000 is down 11.74 points, or 0.5%.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines